STAT Inhibitor OPB-111077, Decitabine and Venetoclax in Treating Patients With Acute Myeloid Leukemia That Is Refractory, Relapsed or Newly Diagnosed and Ineligible for Intensive Chemotherapy

Clinical trial NCT03063944 · COMPLETED

Trial details

NCT number

NCT03063944

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-03-17

Primary completion

2024-01-18

Enrollment

37

View on ClinicalTrials.gov